CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases

AccesswireFeb 27 09:30 ET

Metsera to Present at TD Cowen's 45th Annual Health Care Conference

GlobeNewswireFeb 26 07:00 ET

Metsera Started by Guggenheim at Buy on Obesity Drug Opportunity

Seeking AlphaFeb 25 17:41 ET

Why This Newly Public Biotech Could Become a Force in Obesity Treatments

MarketWatchFeb 25 13:42 ET

Wall Street Bullish on Metsera Following January IPO on Obesity Drug Pipeline

InvestingFeb 25 13:36 ET

Metsera Initiated at Buy by B of A Securities

Dow JonesFeb 25 07:50 ET · Ratings